{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:54:15Z","timestamp":1775523255292,"version":"3.50.1"},"reference-count":40,"publisher":"Wiley","issue":"16","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006919","name":"Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006919","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Caltech George W. Housner Student Discovery Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Rep"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.14814\/phy2.13375","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T00:10:25Z","timestamp":1503101425000},"page":"e13375","source":"Crossref","is-referenced-by-count":3,"title":["A computational model of 1,5-AG dynamics during pregnancy"],"prefix":"10.14814","volume":"5","author":[{"given":"Seyedeh M.","family":"Zekavat","sequence":"first","affiliation":[{"name":"Broad Institute of MIT and Harvard; Cambridge Massachusetts"},{"name":"Massachusetts Institute of Technology; Cambridge Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-595X","authenticated-orcid":false,"given":"Slava","family":"Butkovich","sequence":"additional","affiliation":[{"name":"California Institute of Technology; Pasadena California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace J.","family":"Young","sequence":"additional","affiliation":[{"name":"Harvard Medical School; Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Nathan","sequence":"additional","affiliation":[{"name":"Harvard Medical School; Boston Massachusetts"},{"name":"Massachussetts General Hospital; Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Petrasek","sequence":"additional","affiliation":[{"name":"California Institute of Technology; Pasadena California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"10.14814\/phy2.13375-BIB0001|phy213375-cit-0001","doi-asserted-by":"crossref","first-page":"116ra114","DOI":"10.1126\/scitranslmed.3002693","article-title":"Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in\u00a0vivo spectral-editing and 2D correlation magnetic resonance spectroscopy","volume":"4","author":"Andronesi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.14814\/phy2.13375-BIB0002|phy213375-cit-0002","doi-asserted-by":"crossref","first-page":"248ra104","DOI":"10.1126\/scitranslmed.3009351","article-title":"Genetic validation of a therapeutic target in a mouse model of ALS","volume":"6","author":"Boer","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.14814\/phy2.13375-BIB0003|phy213375-cit-0003","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1515\/cclm-2013-1042","article-title":"1,5 Anhydroglucitol serum concentration as a biomarker for screening gestational diabetes in early pregnancy","volume":"52","author":"Boritza","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.14814\/phy2.13375-BIB0004|phy213375-cit-0004","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/152091503765691839","article-title":"Serum 1,5-anhydroglucitol (GlycoMark): a short-term glycemic marker","volume":"5","author":"Buse","year":"2003","journal-title":"Diabetes Technol. Ther."},{"key":"10.14814\/phy2.13375-BIB0005|phy213375-cit-0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.ackd.2013.01.012","article-title":"Renal physiology of pregnancy","volume":"20","author":"Cheung","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.14814\/phy2.13375-BIB0006|phy213375-cit-0006","volume-title":"Gestational Diabetes Basics","author":"Davidson","year":"2016"},{"key":"10.14814\/phy2.13375-BIB0007|phy213375-cit-0007","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/dc06-1910","article-title":"1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes","volume":"29","author":"Dungan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.14814\/phy2.13375-BIB0008|phy213375-cit-0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.1981.tb00929.x","article-title":"Serial changes in renal haemodynamics during normal human pregnancy","volume":"88","author":"Dunlop","year":"1981","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.14814\/phy2.13375-BIB0009|phy213375-cit-0009","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1464-5491.2005.01752.x","article-title":"Plasma anhydro-D-glucitol (1,5-AG) as an indicator of hyperglycaemic excursions in pregnant women with diabetes","volume":"23","author":"Dworacka","year":"2006","journal-title":"Diabet. Med."},{"key":"10.14814\/phy2.13375-BIB0010|phy213375-cit-0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1471-0528.1981.tb01018.x","article-title":"Non-postural serial changes in renal function during the third trimester of normal human pregnancy","volume":"88","author":"Ezimokhai","year":"1981","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.14814\/phy2.13375-BIB0011|phy213375-cit-0011","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/clinchem\/40.11.2013","article-title":"Fully enzymatic method for determining 1,5-anhydro-D-glucitol in serum","volume":"40","author":"Fukumura","year":"1994","journal-title":"Clin. Chem."},{"key":"10.14814\/phy2.13375-BIB0012|phy213375-cit-0012","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s001250050617","article-title":"Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up","volume":"39","author":"Hanefeld","year":"1996","journal-title":"Diabetologia"},{"key":"10.14814\/phy2.13375-BIB0013|phy213375-cit-0013","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/dc12-0787","article-title":"Alternative markers of hyperglycemia and risk of diabetes","volume":"35","author":"Juraschek","year":"2012","journal-title":"Diabetes Care"},{"key":"10.14814\/phy2.13375-BIB0014|phy213375-cit-0014","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1464-5491.1999.00093.x","article-title":"Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose","volume":"16","author":"Kilpatrick","year":"1999","journal-title":"Diabet. Med."},{"key":"10.14814\/phy2.13375-BIB0015|phy213375-cit-0015","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2337\/diacare.18.8.1156","article-title":"1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM","volume":"18","author":"Kishimoto","year":"1995","journal-title":"Diabetes Care"},{"key":"10.14814\/phy2.13375-BIB0016|phy213375-cit-0016","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.diabres.2010.06.023","article-title":"Habitual intake of dairy products influences serum 1,5-anhydroglucitol levels independently of plasma glucose","volume":"90","author":"Koga","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.14814\/phy2.13375-BIB0017|phy213375-cit-0017","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00125-008-1009-9","article-title":"Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes","volume":"51","author":"Krzyzanowska","year":"2008","journal-title":"Diabetologia"},{"key":"10.14814\/phy2.13375-BIB0018|phy213375-cit-0018","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2337\/diacare.27.8.1859","article-title":"Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay","volume":"27","author":"McGill","year":"2004","journal-title":"Diabetes Care"},{"key":"10.14814\/phy2.13375-BIB0019|phy213375-cit-0019","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1399-5448.2011.00830.x","article-title":"Evaluation of 1,5-anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls","volume":"13","author":"Mehta","year":"2012","journal-title":"Pediatr. Diabetes"},{"key":"10.14814\/phy2.13375-BIB0020|phy213375-cit-0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2337\/diacare.23.1.45","article-title":"Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study","volume":"23","author":"Muggeo","year":"2000","journal-title":"Diabetes Care"},{"key":"10.14814\/phy2.13375-BIB0021|phy213375-cit-0021","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00125-013-2830-3","article-title":"1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus","volume":"56","author":"Nowak","year":"2013","journal-title":"Diabetologia"},{"key":"10.14814\/phy2.13375-BIB0022|phy213375-cit-0022","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1471-0528.1979.tb11240.x","article-title":"Changes in fat, fat-free mass and body water in human normal pregnancy","volume":"86","author":"Pipe","year":"1979","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.14814\/phy2.13375-BIB0023|phy213375-cit-0023","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00003081-197609000-00002","article-title":"Nutritional support in obstetrics and gynecology","volume":"19","author":"Pitkin","year":"1976","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.14814\/phy2.13375-BIB0024|phy213375-cit-0024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc09-1407","article-title":"Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial","volume":"33","author":"Rowan","year":"2010","journal-title":"Diabetes Care"},{"key":"10.14814\/phy2.13375-BIB0025|phy213375-cit-0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/dc11-1641","article-title":"Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study","volume":"35","author":"Sacks","year":"2012","journal-title":"Diabetes Care"},{"key":"10.14814\/phy2.13375-BIB0026|phy213375-cit-0026","doi-asserted-by":"crossref","first-page":"245ra295","DOI":"10.1126\/scitranslmed.3008227","article-title":"An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions","volume":"6","author":"Saito","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"Suppl 2","key":"10.14814\/phy2.13375-BIB0027|phy213375-cit-0027","first-page":"B33","article-title":"The toronto tri-hospital gestational diabetes project. A preliminary review","volume":"21","author":"Sermer","year":"1998","journal-title":"Diabetes Care"},{"key":"10.14814\/phy2.13375-BIB0028|phy213375-cit-0028","first-page":"E821","article-title":"A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control","volume":"273","author":"Stickle","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.14814\/phy2.13375-BIB0029|phy213375-cit-0029","first-page":"754","article-title":"The predictive value of serum 1,5-anhydro-D-glucitol in pregnancies at increased risk of gestational diabetes mellitus and gestational impaired glucose tolerance","volume":"108","author":"Tam","year":"2001","journal-title":"BJOG"},{"key":"10.14814\/phy2.13375-BIB0030|phy213375-cit-0030","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/diacare.23.12.1830","article-title":"Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level","volume":"23","author":"Temelkova-Kurktschiev","year":"2000","journal-title":"Diabetes Care"},{"key":"10.14814\/phy2.13375-BIB0031|phy213375-cit-0031","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/00016349009013322","article-title":"Serum levels of 1,5-anhydro-D-glucitol during the normal and diabetic pregnancy and puerperium","volume":"69","author":"Tetsuo","year":"1990","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.14814\/phy2.13375-BIB0032|phy213375-cit-0032","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.14814\/phy2.13375-BIB0033|phy213375-cit-0033","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/diab.44.8.968","article-title":"The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial","volume":"55","author":"The Diabetes Control and Complications Trial Research Group","year":"1995","journal-title":"Diabetes"},{"key":"10.14814\/phy2.13375-BIB0034|phy213375-cit-0034","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998a","journal-title":"Lancet"},{"key":"10.14814\/phy2.13375-BIB0035|phy213375-cit-0035","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998b","journal-title":"Lancet"},{"key":"10.14814\/phy2.13375-BIB0036|phy213375-cit-0036","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1471-0528.1993.tb15315.x","article-title":"The intravascular mass of albumin during human pregnancy: a serial study in normal and diabetic women","volume":"100","author":"Whittaker","year":"1993","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"Suppl","key":"10.14814\/phy2.13375-BIB0037|phy213375-cit-0037","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1016\/0168-8227(94)90259-3","article-title":"Serum 1,5-anhydroucitol (1,5 AG): new clinical marker for glycemic control","volume":"24","author":"Yamanouchi","year":"1994","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.14814\/phy2.13375-BIB0038|phy213375-cit-0038","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2337\/diab.40.1.52","article-title":"Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus","volume":"40","author":"Yamanouchi","year":"1991","journal-title":"Diabetes"},{"key":"10.14814\/phy2.13375-BIB0039|phy213375-cit-0039","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0026-0495(92)90168-A","article-title":"Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol","volume":"41","author":"Yamanouchi","year":"1992","journal-title":"Metabolism"},{"key":"10.14814\/phy2.13375-BIB0040|phy213375-cit-0040","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(96)90672-8","article-title":"Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control","volume":"347","author":"Yamanouchi","year":"1996","journal-title":"Lancet"}],"container-title":["Physiological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.14814%2Fphy2.13375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.14814\/phy2.13375\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T20:22:33Z","timestamp":1602793353000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.14814\/phy2.13375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.14814\/phy2.13375","archive":["Portico"],"relation":{},"ISSN":["2051-817X"],"issn-type":[{"value":"2051-817X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}